Related Experiment Video
Updated: Jul 19, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease
1Worldwide Biologicals Epidemiology, GlaxoSmithKline Biologicals, Rue de l'Institut 89, B-1330 Rixensart, Belgium. william.P.Hausdorff@gsk.com
Insights
Certain pneumococcal serotypes, like 1 and 5, continue to cause severe invasive pneumococcal disease in children globally. Vaccines targeting these highly virulent serotypes are crucial for public health worldwide.
Area of Science:
- Microbiology
- Epidemiology
- Immunology
Background:
- Invasive pneumococcal disease (IPD) is a significant global health concern, particularly in children.
- A limited number of Streptococcus pneumoniae serotypes are responsible for the majority of IPD cases.
- Serotypes 1 and 5 have historically been prominent causes of disease and remain significant even in the antibiotic era.
Purpose of the Study:
- To highlight the persistent importance of specific pneumococcal serotypes (1 and 5) as causes of invasive disease in children.
- To emphasize the high virulence and public health impact of these serotypes.
- To underscore the need for future vaccine development against these key serotypes.
Main Methods:
- This study is a review and analysis of existing epidemiological data and scientific literature.
- Focus is placed on historical and current disease prevalence attributed to specific pneumococcal serotypes.
- Virulence factors and antimicrobial susceptibility patterns are considered.
Main Results:
- Serotypes 1 and 5 are consistently identified as major contributors to invasive pneumococcal disease in children worldwide.
- Despite the antibiotic era, these serotypes remain prevalent and cause severe illness across all age groups.
- These serotypes exhibit high virulence, leading to disease clusters and outbreaks.
Conclusions:
- Serotypes 1 and 5 of Streptococcus pneumoniae remain critical pathogens causing severe invasive disease in children.
- Their continued prevalence and virulence necessitate ongoing surveillance and intervention strategies.
- Future pneumococcal conjugate vaccines must effectively target these serotypes to reduce global disease burden.
Abstract:
A small number of serotypes are responsible for most invasive pneumococcal disease in children worldwide. Serotypes 1 and 5 were among the first pneumococcal serotypes to be identified, reflecting their great prominence as causes of disease in the early part of the 20th century. In the antibiotic era, these serotypes persist as important causes of disease in children in most countries even though they, unlike some other common serotypes, remain sensitive to antimicrobial agents. These types also exhibit a high level of virulence, cause disease clusters or outbreaks, infect all age groups, and cause severe disease. Future vaccine formulations that protect against these types are important for developed and developing countries alike.
Related Concept Videos
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Atypical Pneumonia
Streptococcal Pharyngitis
Bacterial Meningitis II: Pathophysiology

